Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Back to Library
Vial

Peptide Library / Detail

Pramlintide

Synthetic Amylin AnalogResearch use only

Half-life

~45–60 minutes (SC); pharmacodynamic effects ~2–3 hours

Delivery

Subcutaneous injection immediately prior to major meals (separate site from insulin).

Dosage

Research Use Only

All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.

Purchase

No purchase links available

Description

Pramlintide is a synthetic analog of human amylin, a beta-cell co-secreted peptide with insulin. In research settings it’s used to study postprandial glucose control, gastric emptying, satiety, and glucagon suppression.

Usage

Investigated as an adjunct to mealtime insulin to model reductions in postprandial hyperglycemia and appetite, and to explore amylin physiology in metabolic studies.

Mechanism of Action

Activates amylin receptors to slow gastric emptying, suppress inappropriate postprandial glucagon secretion, and enhance satiety—thereby reducing postprandial glucose excursions.

Benefits(4)

  • Reduces postprandial glucose excursions
  • Decreases glucagon surge after meals
  • Slows gastric emptying
  • May reduce appetite and caloric intake

Side Effects(5)

  • Nausea, vomiting, abdominal discomfort
  • Decreased appetite
  • Injection-site reactions
  • Hypoglycemia when used with insulin (requires mealtime insulin dose reduction)
  • Boxed warning: severe insulin-induced hypoglycemia risk, especially within 3 hours post-dose

Pramlintide — frequently asked questions

  • What is Pramlintide?

    Pramlintide is a synthetic analog of human amylin, a beta-cell co-secreted peptide with insulin. In research settings it’s used to study postprandial glucose control, gastric emptying, satiety, and glucagon suppression.

  • What is the half-life of Pramlintide?

    Pramlintide has an approximate half-life of ~45–60 minutes (SC); pharmacodynamic effects ~2–3 hours. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.

  • How is Pramlintide administered?

    Pramlintide is typically delivered via subcutaneous injection immediately prior to major meals (separate site from insulin).. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.

  • How does Pramlintide work?

    Activates amylin receptors to slow gastric emptying, suppress inappropriate postprandial glucagon secretion, and enhance satiety—thereby reducing postprandial glucose excursions.

  • What are the researched benefits of Pramlintide?

    Studied benefits of Pramlintide include: Reduces postprandial glucose excursions, Decreases glucagon surge after meals, Slows gastric emptying, May reduce appetite and caloric intake. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.

  • What are the side effects of Pramlintide?

    Reported side effects of Pramlintide include: Nausea, vomiting, abdominal discomfort, Decreased appetite, Injection-site reactions, Hypoglycemia when used with insulin (requires mealtime insulin dose reduction), Boxed warning: severe insulin-induced hypoglycemia risk, especially within 3 hours post-dose. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.